Abstract:Subsequently to the publication of the above article, an interested reader drew to the authors' attention that the data panel for the "Huh7+BSA" experiment shown in Fig. 1D on p. 2852, showing the relative size of lipid droplets as determined in morphological studies using oil red O staining, had also appeared previously in the following article published by the same research group [Li D, Cheng M, Niu Y, Chi X, Liu X, Fan J, Fan H, Chang Y and Yang W: Identification of a novel human long non-coding RNA that regulates hepatic lipid metabolism by inhibiting SREBP-1c. Int J Biol Sci 13: 349-357, 2017]. Upon examining their original data, the authors have realized that this data panel was inadvertently selected incorrectly in Fig. 1, and the revised version of Fig. 1, containing the correct data panel for Fig. 1D, is shown on the next page. Note that this error did not significantly affect the results or the conclusions reported in this paper. All the authors agree to the publication of this Corrigendum, and are grateful to the Editor of Molecular Medicine Reports for allowing them the opportunity to correct this error. Moreover, the authors apologize to the readership for any inconvenience caused. [Molecular Medicine Reports 18: 2850-2856, 2018; DOI: 10.3892/mmr.2018.9278]

Erratum: Knockdown of Angiotensinogen by Shrna-Mediated RNA Interference Inhibits Human Visceral Preadipocytes Differentiation

Corrigendum to “from Phenotype to Gene: Detecting Disease‐specific Gene Functional Modules Via a Text‐based Human Disease Phenotype Network Construction” [FEBS Lett. 584 (2010) 3635–3643]

Erratum: Intermedin is upregulated and has protective roles in a mouse ischemia/reperfusion model

Corrigendum to “knockdown of Herp Alleviates Hyperhomocysteinemia Mediated Atherosclerosis Through the Inhibition of Vascular Smooth Muscle Cell Phenotype Switching” [int. J. Cardiol. 269 (2018) 242–249]

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Corrigendum to “the Induction of Reactive Oxygen Species and Loss of Mitochondrial Omi/HtrA2 is Associated with S-nitrosoglutathione-induced Apoptosis in Human Endothelial Cells” [toxicology and Applied Pharmacology 244 (2010) 374–384]

Erratum. Obese Skeletal Muscle–Expressed Interferon Regulatory Factor 4 Transcriptionally Regulates Mitochondrial Branched-Chain Aminotransferase Reprogramming Metabolome. Diabetes 2022;71:2256–2271

Correction: Corrigendum: Inhibitory Receptors Bind ANGPTLs and Support Blood Stem Cells and Leukaemia Development

Correction to: Novel smac mimetic APG-1387 elicits ovarian cancer cell killing through TNF-alpha, Ripoptosome and autophagy mediated cell death pathway (Journal of Experimental and Clinical Cancer Research (2018) 37 (53) DOI: 10.1186/s13046-018-0703-9)

Correction: Corrigendum: N 6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO

Erratum: Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice

Erratum: Adipocytes fuel gastric cancer omental metastasis via PITPNC1-mediated fatty acid metabolic reprogramming: Erratum

Corrigendum to “Cd36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy”

Correction: ZFPM2-AS1, a Novel Lncrna, Attenuates the P53 Pathway and Promotes Gastric Carcinogenesis by Stabilizing MIF.

Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2)

[Corrigendum] Long non‐coding RNA HR1 participates in the expression of SREBP‐1c through phosphorylation of the PDK1/AKT/FoxO1 pathway

Corrigendum to “Differentiation of Adipose-Derived Stem Cells Promotes Regeneration of Smooth Muscle for Ureteral Tissue Engineering” [Journal of Surgical Research 178 (2012) 55-62]

Author Correction to “TMEM16A Inhibits Angiotensin II-induced Basilar Artery Smooth Muscle Cell Migration in a WNK1-dependent Manner” [acta Pharm Sin B 11(12) (2021) 3994–4007]

Erratum: The WW domains dictate isoform-specific regulation of YAP1 stability and pancreatic cancer cell malignancy (Theranostics (2020) 10:10 (4422-4436) DOI: 10.7150/thno.42795)